Givatayim, Israel

Limor Nahary

This inventor holds 3 USPTO granted patents. Top assignee: Tel Aviv University. Active years: 2016-2026.


% Patents Active = 66.7

Average Co-Inventor Count = 6.9

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2016-2026

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Limor Nahary: Innovator in Activatable Toxin Complexes

Introduction

Limor Nahary is a prominent inventor based in Givatayim, Israel. She has made significant contributions to the field of biotechnology, particularly in the development of activatable toxin complexes. With a total of 3 patents, her work is paving the way for innovative treatments in medicine.

Latest Patents

Among her latest patents is the invention titled "SEMAPHORIN 3A ANTIBODIES AND USES THEREOF." This patent focuses on the therapeutic applications of SEMAPHORIN 3A antibodies. Another notable patent is for "Activatable toxin complexes comprising a cleavable inhibitory peptide." This invention relates to complexes that include a cell targeting domain, a toxin catalytic domain, a specific protease cleavage site, and an inhibitory peptide domain. The inhibitory peptide prevents the catalytic domain from exerting toxic effects until its release by the action of a protease. These complexes have potential applications in treating infections and malignant diseases.

Career Highlights

Limor Nahary is affiliated with Tel Aviv University, where she conducts her research and development. Her work is characterized by a strong focus on innovative solutions in the medical field, particularly in the area of targeted therapies.

Collaborations

Some of her notable coworkers include Itai Benhar and Arieh Solomon, who contribute to her research endeavors and collaborative projects.

Conclusion

Limor Nahary's innovative work in activatable toxin complexes and her contributions to biotechnology highlight her role as a leading inventor in her field. Her patents reflect a commitment to advancing medical treatments and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…